Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Other Non-Current Liabilities: 2021-2025

Historic Other Non-Current Liabilities for Core Scientific (CORZ) over the last 5 years, with Sep 2025 value amounting to $1.3 billion.

  • Core Scientific's Other Non-Current Liabilities rose 30.79% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 30.79%. This contributed to the annual value of $1.1 billion for FY2024, which is 1004.63% up from last year.
  • Latest data reveals that Core Scientific reported Other Non-Current Liabilities of $1.3 billion as of Q3 2025, which was up 1.05% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Other Non-Current Liabilities registered a high of $1.3 billion during Q3 2025, and its lowest value of $11.1 million during Q2 2022.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $952.6 million (2023), whereas its average is $796.6 million.
  • Within the past 5 years, the most significant YoY rise in Core Scientific's Other Non-Current Liabilities was 8,459.25% (2023), while the steepest drop was 90.33% (2023).
  • Core Scientific's Other Non-Current Liabilities (Quarterly) stood at $18.5 million in 2021, then skyrocketed by 5,443.75% to $1.0 billion in 2022, then plummeted by 90.33% to $99.3 million in 2023, then spiked by 1,004.63% to $1.1 billion in 2024, then soared by 30.79% to $1.3 billion in 2025.
  • Its last three reported values are $1.3 billion in Q3 2025, $1.3 billion for Q2 2025, and $421.9 million during Q1 2025.